Affymax (AFFY +0.4%) and Takeda Pharmaceuticals (TKPYY.PK) announce that the J-code assigned by...

|By:, SA News Editor

Affymax (AFFY +0.4%) and Takeda Pharmaceuticals (TKPYY.PK) announce that the J-code assigned by the Centers for Medicare and Medicaid Services for Omontys Injection is now effective. This permanent billing code provides streamlined reimbursement for dialysis organizations prescribing the drug for anemia in the United States.